6-K 1 tm2116649d1_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

Form 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2021

 

Commission File Number: 001-39088

 

 

 

Aesthetic Medical International Holdings Group Limited

 

 

 

1122 Nanshan Boulevard

Nanshan District, Shenzhen

Guangdong Province, China 518052

(Address of principal executive offices)

 

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

  Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release - Aesthetic Medical International Holdings Group Limited Announces USD$15.1 Million Private Placement with Lafang China Co., Ltd (拉芳家化股份有限公司)
99.2   English Translation of Share Subscription Agreement, dated as of May 16, 2021, by and among Aesthetic Medical International Holdings Group Limited, Shenzhen Pengai Hospital Investment Management Co., Ltd., and Lafang China Co., Ltd. (拉芳家化股份有限公司)
99.3   English Translation of Control Persons Undertakings

 

2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Aesthetic Medical International Holdings Group Limited
     
  By: /s/ Wu Guanhua
  Name: Wu Guanhua
  Title: Chief Financial Officer
     
Date: May 17, 2021

 

 

3